Nautilus Biotechnology, Inc. (NAUT)
NASDAQ·Healthcare·Biotechnology
$2.16
-0.46%
Mkt Cap $285.93M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$2.50
Range $2.50 – $2.50
Implied Upside
+15.7%
Consensus $2.50 vs current $2.16
NASDAQ·Healthcare·Biotechnology
$2.16
-0.46%
Mkt Cap $285.93M
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$2.50
Range $2.50 – $2.50
+15.7%
Consensus $2.50 vs current $2.16